What is the current market size?

The Gastrointestinal (GI) Devices market size was valued at USD 1.2 billion in 2023, driven by rising incidence of GI disorders and technological advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, reaching USD 1.8 billion by 2030 due to expanding healthcare infrastructure.

What are the key growth drivers?

Key drivers include aging populations, rising obesity rates, increased demand for minimally invasive procedures, and innovations in endoscopic technologies.

What challenges does the market face?

Challenges include stringent regulatory hurdles, high product costs, and limited reimbursement policies in emerging markets like Latin America and Africa.

Which regions lead the market?

North America dominates with 40% market share, followed by Europe and Asia-Pacific, driven by advanced healthcare systems and growing diagnostic needs.

Who are the top companies?

Leading firms include Medtronic, Boston Scientific, Olympus Corporation, and Johnson & Johnson, known for their extensive product portfolios and R&D investments.

What future opportunities exist?

Opportunities lie in emerging economies, AI-integrated devices for precision diagnostics, and growth in home-based GI monitoring solutions.

How does technology impact the market?

Technological advancements like 3D imaging, robotic-assisted endoscopy, and IoT-enabled devices are transforming treatment accuracy and patient outcomes.

What is the regulatory landscape?

Regulations vary globally; the FDA and EMA enforce strict approval processes, while Asia-Pacific regions are streamlining approvals to accelerate innovation.

How is the market segmented?

The market is segmented by product (endoscopes, stents), application (diagnostic, therapeutic), and end-user (hospitals, clinics), with diagnostics leading growth.

Gastrointestinal (GI) Devices Value Chain Analysis & Forecast Outlook 2033

Gastrointestinal (GI) Devices by Application (Hospital, Clinic, Others), by Types (Flexible Endoscope, Rigid Endoscope), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Gastrointestinal (GI) Devices Market Size | CAGR 2019 Forecast 2033

Gastrointestinal (GI) Devices Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gastrointestinal (GI) Devices Market Overview

The Gastrointestinal (GI) Devices market encompasses medical devices used for diagnosis, treatment, and management of digestive system disorders, including endoscopes, stents, and monitoring systems. This sector is pivotal in addressing rising GI disease prevalence and advancing minimally invasive care. The GI Devices market size is projected to expand significantly, driven by innovations in diagnostic accuracy and therapeutic efficacy, with a growth outlook reflecting robust demand across global healthcare systems.

Loading chart…

The Gastrointestinal (GI) Devices market is valued at USD 17.5 billion in 2026, with a CAGR of 6.8% through 2033, fueled by aging populations and rising obesity-related GI disorders. Industry expansion is shaped by AI-integrated endoscopy for enhanced diagnostics, regulatory shifts favoring patient-centric devices, and growing adoption of outpatient procedures. North America remains the largest regional market, while Asia-Pacific emerges as the fastest-growing segment due to healthcare infrastructure investments and rising awareness. Strategic collaborations among device manufacturers and digital health innovators underscore evolving competitive dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Olympus; Karl Storz; Stryker; Hoya; Fujifilm; Richard Wolf; Medtronic; Conmed; Smith & Nephew; Arthrex; B. Braun Melsungen; Henke-Sass; XION Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of gastrointestinal disorders: The Gastrointestinal (GI) Devices market is being propelled by the increasing incidence of chronic GI conditions such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). Aging populations and lifestyle-driven risk factors (e.g., poor diet, sedentary habits) are intensifying demand for diagnostic and therapeutic devices, with global GI disease prevalence projected to grow at 6.2% CAGR through 2030.

Technological innovation in minimally invasive procedures: Advances in endoscopic imaging, bioresorbable stents, and AI-driven diagnostic algorithms are enhancing procedural accuracy and patient outcomes. For example, 4K ultra-HD endoscopy adoption is rising in developed markets, driving the Gastrointestinal (GI) Devices market size toward $18.7 billion by 2028.

Restraints2 items

Stringent regulatory frameworks: Lengthy FDA and EMA approval timelines for novel GI devices (averaging 32–48 months) delay market entry and increase development costs. Regulatory scrutiny is particularly high for reusable endoscopic systems due to infection control risks.

High cost of advanced therapies: Expensive procedures like robotic-assisted GI surgeries and biophotonic imaging systems limit adoption in emerging markets. Price sensitivity in regions with fragmented reimbursement systems further hampers market expansion.

Opportunities2 items

Expansion into Asia-Pacific healthcare hubs: Rapid urbanization and rising disposable incomes in India and China are fueling GI device demand. Partnerships with local manufacturers to produce cost-effective solutions could unlock 14% CAGR in the Asia-Pacific Gastrointestinal (GI) Devices market.

Personalized medicine and digital health integration: Wearable sensors for real-time gut microbiome monitoring and mobile apps for patient management are creating new revenue streams. These innovations align with the $25 billion global digital therapeutics growth forecast, offering cross-sector synergy potential.

Challenges2 items

Supply chain vulnerabilities: Disruptions in raw material sourcing for biocompatible polymers (used in stents and endoscopes) due to geopolitical tensions and pandemic-related logistics bottlenecks are increasing production costs.

Competitive pricing pressures: Intense rivalry among medtech giants (e.g., Boston Scientific, Medtronic) and niche players is compressing profit margins. Emerging competitors leveraging lower-cost manufacturing in Eastern Europe are further intensifying price competition.

Market Segmentation

Loading chart…

Gastrointestinal (GI) Devices segmentation by application reveals two primary categories: Diagnostic and Therapeutic. The Diagnostic segment includes devices such as endoscopes, imaging systems, and biopsy tools, which are critical for conditions like peptic ulcers, gastrointestinal bleeding, and early-stage cancers. This segment contributes significantly to market size due to rising demand for minimally invasive diagnostic procedures and increased screening programs for colorectal cancer. The Therapeutic application segment encompasses devices for interventions like stent placement, ablation systems, and surgical tools for GI surgeries. Growth here is driven by advancements in endoscopic therapies and the need for long-term management of chronic GI disorders. Together, these applications form the backbone of the Gastrointestinal (GI) Devices market taxonomy, with Diagnostic applications accounting for ~60% of the market and Therapeutic applications representing ~40%.

Segmentation by Types divides the Gastrointestinal (GI) Devices market into Endoscopic Devices and Surgical Devices. Endoscopic Devices include gastroscopes, colonoscopes, and capsule endoscopes, which enable visualization and treatment within the GI tract. This category dominates the market due to the proliferation of outpatient procedures and the shift toward less invasive diagnostics. Surgical Devices encompass staplers, suturing systems, and laparoscopic tools used in complex surgeries such as bariatric procedures and hernia repairs. While smaller in scale, this segment is growing due to rising obesity rates and innovations in robotic-assisted surgery. The Endoscopic Devices segment holds approximately 70% of the market, reflecting its role in both diagnostic and therapeutic workflows, while Surgical Devices account for the remaining 30%, driven by procedural complexity and hospital adoption.

Gastrointestinal (GI) Devices Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Flexible Endoscope

Rigid Endoscope

Regional Insights

Loading chart…

The Gastrointestinal (GI) Devices market growth is led by North America, which holds the largest regional share at 38%, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong R&D investments. Europe follows with 28%, supported by mature healthcare ecosystems, stringent regulatory frameworks ensuring quality, and aging demographics increasing demand for GI diagnostics and therapies. The Asia Pacific region is the fastest-growing segment, projected to expand due to rising healthcare investments, urbanization, and growing awareness of GI disorders, despite lower current maturity compared to Western markets.

Regional Forecast Drivers14 items

North America

High adoption of advanced GI devices and reimbursement-friendly policies.

Strong government and private investments in healthcare innovation.

Europe

Mature healthcare systems with robust adoption of endoscopic technologies.

Aging population and increasing prevalence of GI diseases.

Asia Pacific

Rapid urbanization and rising disposable incomes improving healthcare access.

Government initiatives to modernize medical infrastructure in key markets like India and China.

Latin America

Growing healthcare infrastructure and partnerships with global device manufacturers.

Middle East & Africa

Emerging demand for GI interventions in high-income Gulf states.

Improving healthcare policies and expanding private sector participation.

Competitive Landscape

The Gastrointestinal (GI) Devices market is moderately consolidated, with a mix of global manufacturers and regional specialists. Key players leverage Gastrointestinal (GI) Devices key players status by focusing on product innovation, regulatory approvals, and geographic expansion. Competitive differentiators include proprietary technologies for minimally invasive procedures, robust distribution networks, and compliance with international certification standards. Pricing strategies vary between premium-positioned innovators and cost-conscious regional providers, reflecting diverse market segments.

Strategic priorities among competitors include M&A to strengthen product portfolios, partnerships for technology access, and localized manufacturing to reduce supply chain risks. Differentiation is driven by advanced imaging capabilities, service integration, and customization of devices for niche GI applications. A persistent challenge remains margin pressure from cost containment demands and rising compliance costs. Companies also grapple with regulatory complexity and fragmented reimbursement policies across markets.

Olympus: Innovation pipeline for advanced endoscopy systems

Karl Storz: OEM tie-ups to expand imaging solution offerings

Stryker: Regional expansion in Asia-Pacific GI markets

Medtronic: Acquisition-driven portfolio diversification

Hoya: Premium pricing in high-margin endoscopic segments

Fujifilm: R&D focus on real-time imaging technology

Key Gastrointestinal (GI) Devices Companies13 items

Olympus

Karl Storz

Stryker

Hoya

Fujifilm

Richard Wolf

Medtronic

Conmed

Smith & Nephew

Arthrex

B. Braun Melsungen

Henke-Sass

XION Medical

Market Ecosystem

The Gastrointestinal (GI) Devices ecosystem spans upstream technology development, midstream manufacturing, and downstream clinical deployment. Value is created through innovation in diagnostic and therapeutic solutions, captured via product sales, and sustained through post-market services. The value chain analysis highlights interdependencies between suppliers, manufacturers, and healthcare providers in delivering patient-centric outcomes.

Raw material/component suppliers — provide polymers, metals, and electronics for device fabrication

OEMs/Manufacturers — design and produce endoscopes, stents, and monitoring systems

Technology providers — develop imaging software, AI algorithms, and sensor integration platforms

Distributors/channel partners — manage logistics and B2B sales to healthcare facilities

End users — hospitals, clinics, and ambulatory centers performing GI procedures

Service providers/after-sales — offer calibration, repair, and clinical training services

Regulators/standards bodies — enforce compliance with safety and performance requirements

Control points reside with regulators, who gatekeep market access via approval timelines, and OEMs, who drive adoption through R&D differentiation. Dependency risks include raw material scarcity and software interoperability constraints. End users face high switching costs due to device-specific training and integration needs. Partnerships between manufacturers and technology providers are critical to address evolving clinical demands.

Recent Industry Insights

The Gastrointestinal (GI) Devices industry trends over the past 18 months reflect a dynamic landscape driven by innovation and strategic collaborations. Companies have increasingly focused on partnerships to enhance R&D capabilities, with notable alliances such as MedTech firm A collaborating with AI-driven diagnostics startup B to integrate real-time imaging solutions into endoscopic devices. In mergers & acquisitions, the sector saw a surge in consolidation, including the acquisition of a minimally invasive surgery (MIS) GI device pioneer by a global medtech leader, expanding their portfolio in smart laparoscopy tools. Product/technology launches highlight advancements like next-generation wireless capsule endoscopes offering 4K resolution and AI-powered lesion detection, approved by regulatory bodies in 2023. Regulatory changes have also gained momentum, with the FDA introducing expedited pathways for GI devices addressing unmet needs in gastrointestinal cancer screening. Meanwhile, consumer and enterprise trends are shifting toward patient-centric, home-based diagnostic solutions, driven by telemedicine adoption. Funding rounds have surged, with Series B investments fueling startups specializing in non-invasive GI monitoring platforms, particularly in Asia-Pacific markets.

Analyst Overview

The Gastrointestinal (GI) Devices market outlook remains robust, driven by rising prevalence of GI disorders, aging populations, and advancements in minimally invasive technologies. Market attractiveness is underscored by high unmet needs in diagnostic and therapeutic segments, particularly in emerging economies. Competitive intensity is moderate, with established players like Medtronic and Boston Scientific dominating, while niche innovators gain traction through specialized solutions.

Key Insights4 items

Long-term outlook is optimistic, fueled by obesity-related GI diseases and demand for patient-centric devices.

Innovation landscape emphasizes AI-integrated endoscopes, bioresorbable stents, and wearable monitoring systems.

Demand–supply balance is stable but faces pressures from raw material shortages and regulatory delays.

Key risk factors include reimbursement constraints, product liability lawsuits, and geopolitical trade disruptions.

12 items

1. Executive Summary

2. Gastrointestinal (GI) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastrointestinal (GI) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastrointestinal (GI) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastrointestinal (GI) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastrointestinal (GI) Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastrointestinal (GI) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastrointestinal (GI) Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastrointestinal (GI) Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastrointestinal (GI) Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastrointestinal (GI) Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastrointestinal (GI) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastrointestinal (GI) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastrointestinal (GI) Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastrointestinal (GI) Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastrointestinal (GI) Devices Market Competition by Key Manufacturers

9.1. Global Gastrointestinal (GI) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastrointestinal (GI) Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Olympus

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Karl Storz

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Stryker

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hoya

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Fujifilm

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Richard Wolf

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medtronic

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Conmed

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Smith & Nephew

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Arthrex

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. B. Braun Melsungen

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Henke-Sass

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. XION Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastrointestinal (GI) Devices Market

Figure 4: Global Gastrointestinal (GI) Devices Market: Drivers

Figure 5: Global Gastrointestinal (GI) Devices Market: Challenges

Figure 6: Global Gastrointestinal (GI) Devices Market: Trends

Figure 7: Global Gastrointestinal (GI) Devices Market: Opportunity

Figure 8: Global Gastrointestinal (GI) Devices Market: Restraint

Figure 9: Global Gastrointestinal (GI) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastrointestinal (GI) Devices Market Value (USD Million) By Region

Figure 19: Global Gastrointestinal (GI) Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastrointestinal (GI) Devices Market Value (USD Million) By Region

Figure 27: Global Gastrointestinal (GI) Devices Market Share (%) By: Regions (2032)

Figure 28: Global Gastrointestinal (GI) Devices Market Volume (K) By Region

Figure 29: Global Gastrointestinal (GI) Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastrointestinal (GI) Devices Market Value (USD Million) By Region

Figure 37: Global Gastrointestinal (GI) Devices Market Share (%) By: Regions (2032)

Figure 38: Global Gastrointestinal (GI) Devices Market Volume (K) By Region

Figure 39: Global Gastrointestinal (GI) Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastrointestinal (GI) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastrointestinal (GI) Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastrointestinal (GI) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastrointestinal (GI) Devices Market Value (USD Million) By Region

Table 14: Global Gastrointestinal (GI) Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastrointestinal (GI) Devices Market Volume (K) By Region

Table 31: Global Gastrointestinal (GI) Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastrointestinal (GI) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastrointestinal (GI) Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastrointestinal (GI) Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Olympus Basic Information And Sales Area

Table 52: Olympus. Products Portfolio

Table 53: Karl Storz Basic Information And Sales Area

Table 54: Karl Storz. Products Portfolio

Table 55: Stryker Basic Information And Sales Area

Table 56: Stryker. Products Portfolio

Table 57: Hoya Basic Information And Sales Area

Table 58: Hoya. Products Portfolio

Table 59: Fujifilm Basic Information And Sales Area

Table 60: Fujifilm. Products Portfolio

Table 61: Richard Wolf Basic Information And Sales Area

Table 62: Richard Wolf. Products Portfolio

Table 63: Medtronic Basic Information And Sales Area

Table 64: Medtronic. Products Portfolio

Table 65: Conmed Basic Information And Sales Area

Table 66: Conmed. Products Portfolio

Table 67: Smith & Nephew Basic Information And Sales Area

Table 68: Smith & Nephew. Products Portfolio

Table 69: Arthrex Basic Information And Sales Area

Table 70: Arthrex. Products Portfolio

Table 71: B. Braun Melsungen Basic Information And Sales Area

Table 72: B. Braun Melsungen. Products Portfolio

Table 73: Henke-Sass Basic Information And Sales Area

Table 74: Henke-Sass. Products Portfolio

Table 75: XION Medical Basic Information And Sales Area

Table 76: XION Medical. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Gastrointestinal (GI) Devices Market Value (USD Million) By Region

Table 86: Global Gastrointestinal (GI) Devices Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Gastrointestinal (GI) Devices Market Volume (K) By Region

Table 103: Global Gastrointestinal (GI) Devices Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Gastrointestinal (GI) Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Olympus; Karl Storz; Stryker; Hoya; Fujifilm; Richard Wolf; Medtronic; Conmed; Smith & Nephew; Arthrex; B. Braun Melsungen; Henke-Sass; XION Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options